EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Improved targeted delivery of antisense oligonucleotide with an antibody mask

Hung-En Hsia, Chiara Zanini, Claire Simonneau, Johannes Fraidling, Thomas E Kraft, Klaus Mayer, Annika Sommer, Annette Indlekofer, Tamara Wirth, Jörg Benz, Guy Georges iD, Lukas M Langer und 11 weitere

Nucleic Acids Research · 28.10.2025 · 53 (20)

DOI: 10.1093/nar/gkaf487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 30.10.2025. Verfasst von Hung-En Hsia und 22 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg82377, Germany. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, Receptors, Transferrin, Immunoconjugates, Antibodies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Roche Postdoctoral Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antisense oligonucleotides (ASOs) are synthetic nucleic acid strands designed to modulate gene expression by binding to RNA transcripts. In brain diseases, transferrin receptor (TfR)-targeting antibody–ASO conjugates have shown promise for brain delivery of ASOs via transcytosis in preclinical studies. This enables the more patient friendly intravenous or subcutaneous administration of the compounds. However, these conjugates can exhibit faster plasma clearance and different peripheral pharmacokinetic profiles due to ASO modifications, such as phosphorothioate (PS) linkages and locked nucleic acids (LNAs). In this study, we employed an antibody recognizing LNA- and PS-modified ASOs independent of the base sequences as a cloaking module to mitigate these issues. Using Kutzneria albida transglutaminase (KTG) technology and click chemistry, we generated TfR antibody–ASO conjugates with covalently or noncovalently incorporated ASO binders. Additionally, a noncovalent carrier antibody approach was explored. These conjugates and complexes with additional ASO binder(s) show improved TfR-targeted cellular uptake, undergo transcytosis in cellular blood–brain barrier models, show less nonspecific cellular accumulation, and anticipated ASO activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisenseReceptors, TransferrinImmunoconjugatesAntibodiesHumansBlood-Brain BarrierOligonucleotidesAnimalsTranscytosisMiceClick ChemistryPhosphorothioate Oligonucleotides

Substanzen

Oligonucleotides, AntisenseReceptors, TransferrinOligonucleotideslocked nucleic acidImmunoconjugatesAntibodiesPhosphorothioate Oligonucleotides

Autor:innen und Institutionen

  • Roche Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg82377, Germany.
  • Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.
  • Roche Pharma Research and Early Development (pRED), Roche Innovation Center Copenhagen, F. Hoffmann-La Roche Ltd., Hørsholm 2970, Denmark.

ORCID-Profile: Guy Georges, Ulrich Brinkmann

Förderung

  • Roche Postdoctoral Fellowship

Zitieren

APA

Hsia, H. E., Zanini, C., Simonneau, C., Fraidling, J., Kraft, T. E., Mayer, K., Sommer, A., Indlekofer, A., Wirth, T., Benz, J., Georges, G., Langer, L. M., Gassner, C., Larraillet, V., Lohmann, S., Koller, E., Mansø, M., Ravn, J., Hofer, K., …, & Brinkmann, U. (2025). Improved targeted delivery of antisense oligonucleotide with an antibody mask. Nucleic Acids Research, 53(20). https://doi.org/10.1093/nar/gkaf487

Vancouver

Hsia HE, Zanini C, Simonneau C, Fraidling J, Kraft TE, Mayer K, et al. Improved targeted delivery of antisense oligonucleotide with an antibody mask. Nucleic Acids Research. 2025;53(20). doi:10.1093/nar/gkaf487

BibTeX
@article{Hsia2025,
  author = {Hsia, Hung-En and Zanini, Chiara and Simonneau, Claire and Fraidling, Johannes and Kraft, Thomas E and Mayer, Klaus and Sommer, Annika and Indlekofer, Annette and Wirth, Tamara and Benz, Jörg and Georges, Guy and Langer, Lukas M and Gassner, Christian and Larraillet, Vincent and Lohmann, Sabine and Koller, Erich and Mansø, Mads and Ravn, Jacob and Hofer, Kerstin and Emrich, Thomas and Niewöhner, Jens and Schumacher, Felix and Brinkmann, Ulrich},
  title = {Improved targeted delivery of antisense oligonucleotide with an antibody mask},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {20},
  doi = {10.1093/nar/gkaf487}
}
Kostenlos starten →